Aemetis, INC 8-K filings

Aemetis Inc. announced robust second quarter 2026 financial results, featuring a 20% year-over-year revenue increase to $62.7 million, driven by growth in its California Ethanol and Dairy RNG segments, alongside positive gross profit and a significant reduction in net loss.

Aemetis, Inc. held its Annual Meeting of Stockholders on May 20, 2026, where Lydia I. Beebe was elected as a Class II director and KPMG LLP was ratified as the independent auditor.

Aemetis announced first quarter 2026 financial results, showcasing a 27% year-over-year revenue increase to $54.6 million, a significant improvement in gross profit, and growth across its key business segments.

Aemetis, Inc. announced the engagement of KPMG LLP as its new independent registered public accounting firm, replacing RSM US LLP, effective for the quarter ending March 31, 2026.

Aemetis reports strong Q4 2025 results driven by a 61% year-over-year increase in dairy RNG production and anticipates a $32 million annual cash flow boost from ethanol plant upgrades.

Aemetis Biogas LLC secured an extension for its Series A Preferred Unit redemption, but faces a higher aggregate obligation and potentially costly debt terms.

Aemetis, Inc. announced an $80 million share repurchase program, approved executive cash bonuses, and disclosed a $350,000 guarantee fee to its CEO's affiliated entity.

Aemetis reported increased Q3 2025 revenue driven by India OMC orders and stronger ethanol, but also a wider net loss and operating loss compared to the prior year.

Aemetis Biogas LLC secured an extension to redeem preferred units until December 31, 2025, but faces a higher debt principal and a 16% interest rate if not redeemed.

Aemetis reports increased Q2 2025 revenue to $52.2 million driven by India biodiesel and Biogas growth, alongside improved operating and net losses.

Aemetis held its Annual Meeting of Stockholders on May 14, 2025, and announced the results of voting on director elections, auditor ratification, and executive compensation.

Aemetis announces its Q1 2025 financial results, highlighting revenue of $42.9 million and progress in its California Ethanol and Dairy Renewable Natural Gas segments.

Aemetis announces strong 2024 results with a 43% increase in annual revenues, driven by growth across all business segments.

Aemetis subsidiaries extend the maturity date of $136 million in outstanding notes with Third Eye Capital Corporation by one year, now due April 1, 2026.

Aemetis, Inc. amends its at-market issuance sales agreement with H.C. Wainwright & Co., LLC, potentially allowing the company to sell up to $210 million of its common stock.

Aemetis' Governance, Compensation, and Nominating Committee approved revised salaries and one-time bonuses for its named executive officers on January 16, 2025.

Aemetis announced a 19% increase in revenue for the third quarter of 2024 compared to the same period last year, reaching $81.4 million.

Aemetis announced a 48% year-over-year revenue increase to $66.6 million for the second quarter of 2024, driven by strong performance in its ethanol, biodiesel, and renewable natural gas segments.

Aemetis Inc. held its annual meeting on May 29, 2024, where directors were elected and auditors were ratified, but proposals to amend the certificate of incorporation were not approved.

Aemetis saw a significant increase in revenue in the first quarter of 2024, driven by strong performance across its ethanol, biodiesel, and renewable natural gas segments, and secured $200 million in funding for expansion.

Aemetis announced its 2023 fourth quarter and year-end results, highlighting significant revenue growth in its India biodiesel and California renewable natural gas segments, alongside challenges in its ethanol business.

Aemetis projects substantial growth in revenue and adjusted EBITDA, reaching $1.95 billion and $645 million respectively by 2028, driven by renewable natural gas, sustainable aviation fuel, and other renewable fuel initiatives.

Aemetis subsidiaries have extended the maturity date of $117.2 million in debt to April 1, 2025, providing the company with additional financial flexibility.

Aemetis Biogas LLC has amended its agreement with Protair-X Americas, Inc. and Third Eye Capital Corporation, extending the deadline to redeem preferred units and increasing the redemption price.